Portal de Periódicos da CAPES

AIDS-Related Kaposi Sarcoma, Version 2.2019

2019; National Comprehensive Cancer; Volume: 17; Issue: 2 Linguagem: Inglês

10.6004/jnccn.2019.0008

1540-1413

Erin Reid, Gita Suneja, Richard F. Ambinder, Kevin L. Ard, Robert A. Baiocchi, Stefan K. Barta, Evie H. Carchman, Adam K. Cohen, Oxana Crysler, Neel K. Gupta, Chelsea Gustafson, Allison Hall, Kimberly L. Johung, Ann H. Klopp, Ann S. LaCasce, Chi Lin, Amitkumar Mehta, Manoj Menon, David Morgan, Nitya Nathwani, Ariela Noy, Lee Ratner, Stacey A. Rizza, Michelle A. Rudek, Julian Sanchez, Jeff Taylor, Benjamin Tomlinson, Chia-Ching J. Wang, Sai Yendamuri, Mary A. Dwyer, Deborah A. Freedman-Cass,

Polyomavirus and related diseases

As treatment of HIV has improved, people living with HIV (PLWH) have experienced a decreased risk of AIDS and AIDS-defining cancers (non-Hodgkin’s lymphoma, Kaposi sarcoma, and cervical cancer), but the risk of Kaposi sarcoma in PLWH is still elevated about 500-fold compared with the general population in the United States. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AIDS-Related Kaposi Sarcoma provide diagnosis, treatment, and surveillance recommendations for PLWH who develop limited cutaneous Kaposi sarcoma and for those with advanced cutaneous, oral, visceral, or nodal disease.